Kausale Therapie von Prionerkrankungen Entwicklung und Charakterisierung neuartiger anti-aggregativer Wirkstoffe in vitro und in vivo

The collection of the requested information is necessary to process your request. Depending on the ranges and industries you have selected in this form, we will send you targeted scientific information (White Papers, Application Notes, Articles) and, occasionally, service offers, event invitations or any other information related to our activity. To know and exercise your rights, including the withdrawal of your consent to use the data collected by this form, please consult our privacy policy.